Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
ImmuPharma PLC (AIM:IMM, FRA:25I) CEO Tim McCarthy joined Stephen Gunnion in the Proactive studio to discuss the company's latest developments, including progress on its lead asset P140, a newly ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Good afternoon, ladies and gentlemen, and welcome to the ImmuPharma plc corporate update. [Operator Instructions] Due to the significant attendance on today's call, the company may not be in a ...
Add Yahoo as a preferred source to see more of our stories on Google. LONDON (Reuters) - British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for ...
ImmuPharma advances P140 partnering talks as patent progress and new study data strengthen programme
ImmuPharma PLC (AIM:IMM, FRA:25I), the AIM-listed specialist drug discovery and development company, is progressing discussions with a number of potential partners for its P140 autoimmune technology ...
ImmuPharma PLC (AIM:IMM, FRA:25I) shares jumped 20% to 5.48p after the AIM-listed specialist drug discovery and development company said it is progressing discussions with a number of potential ...
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. ImmuPharma was the winner of the New Economy Pharmaceutical & Healthcare Awards for 2010. This adds to two recent ...
The firm has a market capitalization of £20.11 million, a price-to-earnings ratio of -483.00 and a beta of 1.53. The firm has a 50 day moving average price of GBX 2.46 and a 200-day moving average ...
ImmuPharma PLC Annual stock financials by MarketWatch. View the latest 25I financial statements, income statements and financial ratios.
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results